RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
U-Neuron Biomedical Stock

U-Neuron Biomedical P/S 2024

U-Neuron Biomedical P/S

0

Ticker

6973.TWO

ISIN

TW0006973001

As of Dec 12, 2024, U-Neuron Biomedical's P/S ratio stood at 0, a 0% change from the 0 P/S ratio recorded in the previous year.

The U-Neuron Biomedical P/S history

U-Neuron Biomedical Aktienanalyse

What does U-Neuron Biomedical do?

U-Neuron Biomedical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding U-Neuron Biomedical's P/S Ratio

U-Neuron Biomedical's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing U-Neuron Biomedical's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating U-Neuron Biomedical's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in U-Neuron Biomedical’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about U-Neuron Biomedical stock

What is the price-to-earnings ratio of U-Neuron Biomedical?

The price-earnings ratio of U-Neuron Biomedical is currently 0.

How has the price-earnings ratio of U-Neuron Biomedical changed compared to last year?

The price-to-earnings ratio of U-Neuron Biomedical has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of U-Neuron Biomedical high compared to other companies?

Yes, the price-to-earnings ratio of U-Neuron Biomedical is high compared to other companies.

How does an increase in the price-earnings ratio of U-Neuron Biomedical affect the company?

An increase in the price-earnings ratio of U-Neuron Biomedical would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of U-Neuron Biomedical affect the company?

A decrease in the price-earnings ratio of U-Neuron Biomedical would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of U-Neuron Biomedical?

Some factors that influence the price-earnings ratio of U-Neuron Biomedical are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does U-Neuron Biomedical pay?

Over the past 12 months, U-Neuron Biomedical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, U-Neuron Biomedical is expected to pay a dividend of 0 TWD.

What is the dividend yield of U-Neuron Biomedical?

The current dividend yield of U-Neuron Biomedical is .

When does U-Neuron Biomedical pay dividends?

U-Neuron Biomedical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of U-Neuron Biomedical?

U-Neuron Biomedical paid dividends every year for the past 0 years.

What is the dividend of U-Neuron Biomedical?

For the upcoming 12 months, dividends amounting to 0 TWD are expected. This corresponds to a dividend yield of 0 %.

In which sector is U-Neuron Biomedical located?

U-Neuron Biomedical is assigned to the 'Health' sector.

Wann musste ich die Aktien von U-Neuron Biomedical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of U-Neuron Biomedical from 12/12/2024 amounting to 0 TWD, you needed to have the stock in your portfolio before the ex-date on 12/12/2024.

When did U-Neuron Biomedical pay the last dividend?

The last dividend was paid out on 12/12/2024.

What was the dividend of U-Neuron Biomedical in the year 2023?

In the year 2023, U-Neuron Biomedical distributed 0 TWD as dividends.

In which currency does U-Neuron Biomedical pay out the dividend?

The dividends of U-Neuron Biomedical are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von U-Neuron Biomedical

Our stock analysis for U-Neuron Biomedical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of U-Neuron Biomedical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.